Carcinoid Tumors
March 2022 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Carcinoid Tumors abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Carcinoid Tumors. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Carcinoid Tumors. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Carcinoid Tumors every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:A Case of Carcinoid Tumors in the Ear Canal With Long-Term Postoperative Follow-Up.
Authors:Tanahashi S, Oonishi M, Mori K, Umeda M, Wakaoka T, Takahashi H
Institution:Department of Otorhinolaryngology, Gifu Municipal Hospital, Gifu, Japan. Department of Otorhinolaryngology, Japanese Red Cross Takayama Hospital, Takayama, Japan.
Journal:J Int Adv Otol. 2021 Nov;17(6):577-580. doi: 10.5152/iao.2021.21230.

2:Primary ovarian mucinous carcinoid arising in a mature cystic teratoma-A rare entity.
Authors:Thomas BM, Joseph E, Mathew R, Kurien JS
Institution:Department of Pathology, Believers Church Medical College Hospital, Thiruvalla, Kerala, India. Department of Surgery, Believers Church Medical College Hospital, Thiruvalla, Kerala, India.
Journal:Indian J Pathol Microbiol. 2022 Jan-Mar;65(1):184-186. doi: 10.4103/IJPM.IJPM_1357_20.

3:Ligation-assisted endoscopic mucosal resection has high complete resection rate in rectal carcinoid tumor.
Authors:Su MY, Chiu CT
Institution:Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, 6, Sec 2, Jincheng Rd, Tucheng Dist, New Taipei City, Taiwan, Republic of China. doctorsmy54@gmail.com. Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital Linkou Branch, Taoyuan, Taiwan.
Journal:BMC Gastroenterol. 2021 Dec 13;21(1):464. doi: 10.1186/s12876-021-02061-4.

4:Isolated metastasis of mediastinal carcinoid to the left ventricle: A case report.
Authors:Wu HH, Wang LH, Li HY
Institution:Department of Echocardiography, Yuhuangding Hospital?Qingdao University, Yantai, China. Department of Pharmacy, Yuhuangding Hospital, Qingdao University, Yantai, China.
Journal:Echocardiography. 2021 Dec;38(12):2091-2094. doi: 10.1111/echo.15253. Epub 2021 Nov 21.

5:Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour.
Authors:Sun TY, Hwang G, Pancirer D, Hornbacker K, Codima A, Lui NS, Raj R, Kunz P, Padda SK
Institution:Stanford University School of Medicine, Division of Oncology, Dept of Medicine, Stanford, CA, USA. Stanford University School of Medicine, Division of Oncology, Dept of Medicine, Stanford, CA, USA Sukhmani.Padda@cshs.org.
Journal:Eur Respir J. 2022 Jan 27;59(1):2101058. doi: 10.1183/13993003.01058-2021. Print 2022 Jan.

6:Neuroendocrine Tumors of the Lung.
Authors:Randhawa S, Trikalinos N, Patterson GA
Institution:Division of Thoracic Surgery, Department of Surgery, Washington University School of Medicine, 1 Barnes Jewish Hospital, St Louis, MO 63110, USA. Electronic address: srandhawa@wustl.edu.
Journal:Thorac Surg Clin. 2021 Nov;31(4):469-476. doi: 10.1016/j.thorsurg.2021.05.005.

7:Cushing's syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review.
Authors:Bostan H, Duger H, Akhanli P, Calapkulu M, Turkmenoglu TT, Erdol AK, Duru SA, Sencar ME, Kizilgul M, Ucan B, Ozbek M, Cakal E
Institution:Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, ?ht. Omer Halisdemir Blv. No. 1, 6110, Ankara, Turkey. drhayribostan@gmail.com.
Journal:Hormones (Athens). 2022 Mar;21(1):147-154. doi: 10.1007/s42000-021-00316-z. Epub 2021 Sep 3.

8:Outcomes and periprocedural management of cardiac implantable electronic devices in patients with carcinoid heart disease.
Authors:Ward RC, Luis SA, Shabtaie SA, Pellikka PA, Connolly HM, Miranda W, Schaff H, Shen WK, Killu AM, Cha YM, Asirvatham SJ, Deshumkh AJ, DeSimone CV
Institution:Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. address: desimone.christopher@mayo.edu.
Journal:Heart Rhythm. 2021 Dec;18(12):2094-2100. doi: 10.1016/j.hrthm.2021.08.021. Epub 2021 Aug 21.

9:A Systematic Review of Economic and Quality-of-Life Research in Carcinoid Syndrome.
Authors:Pan IW, Halperin DM, Kim B, Yao JC, Shih YT
Institution:Section of Cancer Economics and Policy, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1444, Houston, TX, 77030, USA. ipan@mdanderson.org. Cancer Center, Houston, TX, USA. University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1444, Houston, TX, 77030, USA. Cancer Center, Houston, TX, USA. University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1444, Houston, TX, 77030, USA.
Journal:Pharmacoeconomics. 2021 Nov;39(11):1271-1297. doi: 10.1007/s40273-021-01071-0. Epub 2021 Aug 11.

10:Long-term effect of everolimus in recurrent thymic neuroendocrine neoplasia.
Authors:Lang M, Hackert T, Anamaterou C
Institution:Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Heidelberg, Germany. Heidelberg, Heidelberg, Germany.
Journal:Clin Endocrinol (Oxf). 2021 Nov;95(5):744-751. doi: 10.1111/cen.14572. Epub 2021 Aug 26.

11:Pineal Gland Metastasis From Gastric Carcinoid-A Rare Manifestation.
Authors:Fine GC, Zhu GG, Morton KA, Damme N, Koppula BR
Institution:From the Department of Radiology and Imaging Sciences, University of Utah School of Medicine, Salt Lake City, UT.
Journal:Clin Nucl Med. 2022 Jan 1;47(1):56-58. doi: 10.1097/RLU.0000000000003818.

12:Treatment of Pulmonary Carcinoid Tumors With Bronchoscopic Cryotherapy: A 28-Year Single-center Experience.
Authors:Perikleous P, Mayer N, Finch J, Beddow E, Anikin V, Asadi N
Institution:Department of Thoracic Surgery, Harefield Hospital, Middlesex, England, UK.
Journal:J Bronchology Interv Pulmonol. 2022 Jan 1;29(1):71-82. doi: 10.1097/LBR.0000000000000791.

13:A unique case of a typical carcinoid of the middle mediastinum: en bloc surgical resection on cardiopulmonary bypass.
Authors:Rizzardi G, Brascia D, Marulli G, Bortolotti L
Institution:Department of Thoracic Surgery, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
Journal:Interact Cardiovasc Thorac Surg. 2021 Nov 22;33(6):995-997. doi: 10.1093/icvts/ivab192.

14:A prospective study of carcinoid crisis with no perioperative octreotide.
Authors:Wonn SM, Ratzlaff AN, Pommier SJ, McCully BH, Pommier RF
Institution:Division of Surgical Oncology, Department of Surgery, Oregon Health & Science University, Portland, OR. Electronic address: pommierr@ohsu.edu.
Journal:Surgery. 2022 Jan;171(1):88-93. doi: 10.1016/j.surg.2021.03.063. Epub 2021 Jul 3.

15:Appendiceal goblet-cell adenocarcinoma: a rare cause of acute appendicitis.
Authors:Pérez Montiel CA, Murillo Salas MA, Redondo Bermúdez C
Institution:Patología, Hospital Universitario del Caribe, Colombia.
Journal:Rev Esp Enferm Dig. 2021 Nov;113(11):799-800. doi: 10.17235/reed.2021.8056/2021.

16:Morbidity and extent of surgical resection of carcinoid tumors after endobronchial treatment.
Authors:Reuling EMBP, Naves DD, Hartemink KJ, van der Heijden EHFM, Plaisier PW, Verhagen AFTM, Daniels JMA, Dickhoff C
Institution:Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands; Department of Surgery, Albert Schweitzer Hospital, Dordrecht, the Netherlands. Electronic address: e.reuling@amsterdamumc.nl. Amsterdam, the Netherlands. Netherlands. the Netherlands. The Netherlands. Amsterdam, the Netherlands; Department of Cardiothoracic Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands. Electronic address: c.dickhoff@amsterdamumc.nl.
Journal:Eur J Surg Oncol. 2021 Dec;47(12):2989-2994. doi: 10.1016/j.ejso.2021.05.025. Epub 2021 May 18.

17:Cyclic ACTH-secreting thymic carcinoid: a case report and review of the literature.
Authors:Lamback EB, de Almeida SA, Terra R, Ferreira CG, Capelozzi VL, Haddad R, Gadelha MR
Institution:Unidade de Medicina Interna e Serviço de Endocrinologia, Faculdade de Medicina e Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil. Janeiro, RJ, Brasil. Paulo Niemeyer, Rio de Janeiro, RJ, Brasil. Janeiro, RJ, Brasil. Janeiro, RJ, Brasil. das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brasil. RJ, Brasil. de São Paulo, São Paulo, SP, Brasil. Janeiro, RJ, Brasi. Rio de Janeiro, RJ, Brasil. Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil, mgadelha@hucff.ufrj.br. Janeiro, RJ, Brasil. Paulo Niemeyer, Rio de Janeiro, RJ, Brasil.
Journal:Arch Endocrinol Metab. 2021 Nov 3;65(4):512-516. doi: 10.20945/2359-3997000000346. Epub 2021 Apr 12.

For a FREE PREVIEW of the Medifocus Guidebook on Carcinoid Tumors click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Carcinoid Tumors click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Carcinoid Tumors...
at a Special 20% Discount


Medifocus Guidebook on Carcinoid Tumors

Updated: January 2, 2022
183 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Carcinoid Tumors is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $49.95
  • Less 20% Discount = - $10.00
  • Discounted Price = $39.95(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $34.95
  • Less 20% Discount = - $7.00
  • Discounted Price = $27.95

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

CT340420409

Coupon Expires: September 18, 2022



What Our Customers Are Saying...

"The MediFocus Guidebook on Carcinoid Tumors helped me prepare for my operation. It was reassuring to be able to communicate with my surgeon and the consulting doctors having knowledge about my condition."
P.T.
Newcastle, England


"The Guide is detailed and written in a way that the layman can readily understand. My wife, who has just had a Carcinoid Tumor removed, is reading it as I write this. It will be helpful in her recovery and ongoing therapy."
F.B.
Nanaimo, British Columbia


"The MediFocus Guidebook on Carcinoid Tumors was extremely informative and easy to understand. Now I'm able to discuss my condition with my doctor in an informed manner and make better decisions regarding my treatment."
J.P.F.
Agoura Hills, California



  
Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2022 Medifocus, Inc. All rights reserved.